Get the Stockscreener App
17.25
1.05%
0.16
Staar Surgical Co stock is traded at $17.25, with a volume of 133.09K.
It is up +1.05% in the last 24 hours and up +3.85% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
See More
Previous Close:
$17.09
Open:
$17.01
24h Volume:
133.09K
Relative Volume:
0.17
Market Cap:
$853.58M
Revenue:
$341.22M
Net Income/Loss:
$21.78M
P/E Ratio:
39.20
EPS:
0.44
Net Cash Flow:
$26.30M
1W Performance:
-3.03%
1M Performance:
+3.85%
6M Performance:
-22.52%
1Y Performance:
-60.95%
1-Day Range:
$17.01
$17.42
1-Week Range:
$16.80
$17.68
52-Week Range:
$13.50
$44.48
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
17.23 | 848.88M | 341.22M | 21.78M | 26.30M | 0.44 |
|
ISRG
Intuitive Surgical Inc
|
514.79 | 189.29B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
178.34 | 50.30B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
86.19 | 43.02B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
255.52 | 37.53B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
222.90 | 16.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
Principal Financial Group Inc. Raises Position in STAAR Surgical Company (NASDAQ:STAA) - Defense World
Why STAAR Surgical Company stock attracts strong analyst attentionInstant Stock Updates - Newser
Implantable Collamer Lens Market is expected to reach US$ 810 - openPR.com
3 Reasons to Sell STAA and 1 Stock to Buy Instead - Yahoo Finance
STAAR Surgical (NASDAQ:STAA) vs. Golf Rounds.com (OTCMKTS:FZMD) Head-To-Head Comparison - Defense World
Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo
Midday Stock Roundup: Glaukos Falls - Orange County Business Journal
Staar Surgical Co. Reaches Analyst Target Price - Nasdaq
Intraocular Lens Market The Future of Industry: Promising Innovations (2025-2032) - newstrail.com
Wealth Enhancement Advisory Services LLC Purchases 9,125 Shares of STAAR Surgical Company (NASDAQ:STAA) - Defense World
Head to Head Comparison: STAAR Surgical (NASDAQ:STAA) and McKesson (NYSE:MCK) - Defense World
State of Alaska Department of Revenue Sells 710 Shares of STAAR Surgical Company (NASDAQ:STAA) - Defense World
STAAR Surgical appoints Deborah Andrews as CFO By Investing.com - Investing.com Nigeria
Staar Surgical Holds Annual Shareholders Meeting - TipRanks
Piper Sandler maintains neutral rating on STAAR Surgical stock amid China woes By Investing.com - Investing.com South Africa
Piper Sandler maintains neutral rating on STAAR Surgical stock amid China woes - Investing.com India
Rhumbline Advisers Sells 706 Shares of STAAR Surgical (NASDAQ:STAA) - Defense World
Bright Future: Cataract Surgery Devices Market Soars to $12.2B by 2030 with Innovation - newstrail.com
Staar Surgical Co (STAA) Shares Gap Down to $17.535 on Jun 11 - GuruFocus
STAA Q1 Earnings Call: Tariff Mitigation, Cost Cuts, and China Inventory Reshape Outlook - Yahoo Finance
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 13,075 Shares of STAAR Surgical (NASDAQ:STAA) - Defense World
Intraocular Lens Market Emerging Tech Trends to Watch from 2025 to 2032 - newstrail.com
STAAR Surgical at William Blair Conference: Strategic Shifts Amid Challenges By Investing.com - Investing.com South Africa
STAAR Surgical at William Blair Conference: Strategic Shifts Amid Challenges - Investing.com Australia
Staar Surgical Co (STAA) Trading Down 5.84% on Jun 2 - GuruFocus
Staar Surgical Co (STAA) Trading Down 3.22% on May 30 - GuruFocus
Phakic Intraocular Lens Manufacturing 2025: Market Surge & Innovation Unveiled - macholevante.com
Staar Surgical Co (STAA) Stock Price Down 4.12% on May 28 - GuruFocus
Why LASIK Isn't for Everyone: Houston Lasik & Eye Introduces EVO ICL as a Personalized Solution - USA Today
Canaccord Genuity Maintains Hold Rating for STAA with $20 Price Target | STAA Stock News - GuruFocus
STAAR Surgical (NASDAQ:STAA) Receives Hold Rating from Canaccord Genuity Group - Defense World
STAAR Surgical at Stifel Forum: Strategic Moves and Market Challenges - Investing.com Australia
STAAR Surgical at Stifel Forum: Strategic Moves and Market Challenges By Investing.com - Investing.com India
Staar Surgical Q1 Sales Drop 45% on Weak China Demand - Orange County Business Journal
Deutsche Bank AG Has $1.10 Million Stake in STAAR Surgical (NASDAQ:STAA) - Defense World
Ameriprise Financial Inc. Raises Position in STAAR Surgical (NASDAQ:STAA) - Defense World
STAAR Surgical Announces Participation in Upcoming Investor Conferences - Business Wire
Fortune Brands, Whirlpool, Align Technology, Tandem Diabetes, and STAAR Surgical Shares Plummet, What You Need To Know - Yahoo Finance
Staar Surgical (STAA) Receives 'Hold' Rating Reiteration from Ne - GuruFocus
STAAR Surgical stock target raised at Jefferies to $21 By Investing.com - Investing.com South Africa
STAAR Surgical stock target raised at Jefferies to $21 - Investing.com Australia
STAAR Surgical (NASDAQ:STAA) Shares Bought by BNP Paribas Financial Markets - Defense World
STAAR Surgical Company look to conduct $30M share buyback program - MSN
Staar Surgical Co (STAA) Getting Ready To Launch, Waiting For The Long Term Buyers - Stocksregister
Northern Trust Corp Reduces Stock Holdings in STAAR Surgical (NASDAQ:STAA) - Defense World
STAAR Surgical authorizes $30 million stock buyback By Investing.com - Investing.com South Africa
STAAR Surgical authorizes $30 million stock buyback - Investing.com Australia
Staar Surgical Announces $30 Million Share Repurchase Authorization - marketscreener.com
Staar Surgical (STAA) Board Approves $30 Million Share Buyback | - GuruFocus
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Staar Surgical Co Stock (STAA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 09 '25 |
Buy |
15.08 |
8,200 |
123,676 |
13,518,591 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 10 '25 |
Buy |
15.18 |
900 |
13,658 |
13,519,491 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 04 '25 |
Buy |
15.91 |
497,631 |
7,917,191 |
13,194,210 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 03 '25 |
Buy |
16.97 |
209,535 |
3,555,138 |
12,696,579 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 07 '25 |
Buy |
15.61 |
138,054 |
2,155,174 |
13,332,264 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Apr 02 '25 |
Buy |
17.43 |
31,780 |
553,925 |
12,487,044 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Mar 31 '25 |
Buy |
17.46 |
22,189 |
387,360 |
12,455,264 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Mar 26 '25 |
Buy |
17.50 |
101,633 |
1,778,517 |
12,421,324 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Mar 28 '25 |
Buy |
17.47 |
8,131 |
142,014 |
12,433,075 |
| BROADWOOD PARTNERS, L.P. | 10% Owner |
Mar 27 '25 |
Buy |
17.48 |
3,620 |
63,294 |
12,424,944 |
0.48%
1.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):